Vietnam Investment Review on MSN
CO PSMA prostate imaging data presented at EAU congress
SYDNEY, March 17, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that ...
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
P.S.S. Urology, Inc. ('P.S.S. Urology”), a next-generation U.S. medical device distributor delivering clinically proven, cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results